Healthcare provider profile · identity verified

Crystal Mendonsa, DNP

Nurse Practitioner · FALL RIVER, MA · NPI 1871043729

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Warfarin Sodium	Warfarin Sodium	280	12
Trazodone Hcl	Trazodone Hcl	223	60
Tramadol Hcl	Tramadol Hcl	194	44
Levothyroxine Sodium	Levothyroxine Sodium	177	18
Mirtazapine	Mirtazapine	170	28
Lorazepam	Lorazepam	165	34
Potassium Chloride	Potassium Chloride	158	33
Alprazolam	Alprazolam	147	19
Escitalopram Oxalate	Escitalopram Oxalate	122	22
Sertraline Hcl	Sertraline Hcl	112	suppressed
Oxycodone Hcl	Oxycodone Hcl	111	31
Gabapentin	Gabapentin	104	20
Atorvastatin Calcium	Atorvastatin Calcium	93	17
Eliquis	Apixaban	87	11
Furosemide	Furosemide	80	27
Risperidone	Risperidone	75	suppressed
Amlodipine Besylate	Amlodipine Besylate	74	15
Prednisone	Prednisone	74	20
Tradjenta	Linagliptin	63	suppressed
Oxycontin	Oxycodone Hcl	60	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	60	11
Metoprolol Tartrate	Metoprolol Tartrate	59	12
Metoprolol Succinate	Metoprolol Succinate	56	14
Pantoprazole Sodium	Pantoprazole Sodium	54	11
Bumetanide	Bumetanide	45	suppressed
Lisinopril	Lisinopril	45	16
Fentanyl	Fentanyl	41	suppressed
Januvia	Sitagliptin Phosphate	41	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Memantine Hcl	Memantine Hcl	40	suppressed
Omeprazole	Omeprazole	39	suppressed
Divalproex Sodium	Divalproex Sodium	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Metformin Hcl	Metformin Hcl	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	15
Jardiance	Empagliflozin	31	suppressed
Simvastatin	Simvastatin	29	suppressed
Sucralfate	Sucralfate	29	suppressed
Jantoven	Warfarin Sodium	28	suppressed
Olanzapine	Olanzapine	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Nystatin	Nystatin	27	12
Ondansetron Hcl	Ondansetron Hcl	27	11
Baclofen	Baclofen	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	suppressed
Lacosamide	Lacosamide	26	suppressed
Morphine Sulfate Er	Morphine Sulfate	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Methenamine Hippurate	Methenamine Hippurate	21	suppressed
Famotidine	Famotidine	20	suppressed
Levofloxacin	Levofloxacin	20	19
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	19	suppressed
Ramipril	Ramipril	19	suppressed
Constulose	Lactulose	18	suppressed
Morphine Sulfate	Morphine Sulfate	18	14
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	17	suppressed
Nuplazid	Pimavanserin Tartrate	17	suppressed
Rivastigmine	Rivastigmine Tartrate	17	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	17	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	17	suppressed
Torsemide	Torsemide	17	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Admelog Solostar	Insulin Lispro	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	12	suppressed
Neupro	Rotigotine	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Topiramate	Topiramate	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Enulose	Lactulose	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error